procainamide has been researched along with Agranulocytosis in 42 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
Excerpt | Relevance | Reference |
---|---|---|
"A 71-year-old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited granulocytopenia 8 days following the administration of oral sustained-release procainamide (750 mg/day)." | 7.69 | Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction. ( Abe, H; Kuroiwa, A; Suzuka, H; Tasaki, H, 1995) |
"Agranulocytosis is a well recognized but uncommon complication of procainamide (PA) therapy, whereas a lupus-like syndrome occurs in approximately 20% of patients treated chronically with PA." | 7.69 | Procainamide-induced agranulocytosis differs serologically and clinically from procainamide-induced lupus. ( Creamer, JI; Kenyon, CM; Rubin, RL; Simrell, CR; Starkebaum, G, 1996) |
"A 56-year-old man developed procainamide-induced agranulocytosis." | 7.67 | Procainamide-induced agranulocytosis with reversible myeloid sensitivity. ( Fass, AE; Lutton, JD; Nelson, JC, 1984) |
"We have described six new patients accounting for seven episodes of agranulocytosis due to procainamide." | 7.67 | Procainamide-induced agranulocytosis. ( Reidy, TJ; Upshaw, JD, 1984) |
"Neutropenia is a rare complication of procainamide therapy." | 7.67 | Severe neutropenia associated with sustained-release procainamide. ( Ellrodt, AG; Gray, R; Mochizuki, C; Murata, GH; Riedinger, MS; Stewart, ME, 1984) |
"With increased use of sustained-release forms of procainamide in treating common cardiac arrhythmias, more and more cases of severe neutropenia and occasional deaths have been reported." | 7.67 | Severe neutropenia due to sustained-release procainamide. ( Hoyt, RE, 1987) |
"Procainamide therapy has frequently been reported as a cause of agranulocytosis, but severe thrombocytopenia associated with the use of this drug has been noted only once." | 7.66 | Procainamide-induced agranulocytosis and thrombocytopenia. ( Amorosi, EL; Rothman, IK, 1979) |
"Bone marrow granulomas and neutropenia occurred in a 77-year-old man following the ingestion of procainamide hydrochloride for 50 days." | 7.66 | Bone marrow granulomas and neutropenia associated with procainamide. Report of a case. ( Baker, J; Riker, J; Swanson, M, 1978) |
"The case of a 69-year-old woman with procainamide-induced agranulocytosis is reported, and literature reports of 14 other such cases are reviewed." | 7.65 | Agranulocytosis associated with procainamide therapy--report of a case. ( Brown, BT; Jacknowitz, AI; Prince, RA, 1977) |
"A 73-year-old woman was found to have clinically significant pancytopenia in association with procainamide hydrochloride ingestion." | 7.65 | Severe transient pancytopenia associated with procainamide ingestion. ( Bluming, AZ; Plotkin, D; Rosen, P; Thiessen, AR, 1976) |
"We have presented two cases of agranulocytosis occurring in patients receiving a combination antiarrhythmic regimen." | 5.26 | Agranulocytosis during combined procainamide and phenytoin therapy. ( Crook, JE; Leftwich, RB; Natelson, EA; Woosley, RL, 1979) |
"A 71-year-old man with paroxysmal atrial fibrillation who had a previous anterior myocardial infarction exhibited granulocytopenia 8 days following the administration of oral sustained-release procainamide (750 mg/day)." | 3.69 | Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction. ( Abe, H; Kuroiwa, A; Suzuka, H; Tasaki, H, 1995) |
"Neutropenia is a rare complication of procainamide therapy." | 3.67 | Severe neutropenia associated with sustained-release procainamide. ( Ellrodt, AG; Gray, R; Mochizuki, C; Murata, GH; Riedinger, MS; Stewart, ME, 1984) |
"With increased use of sustained-release forms of procainamide in treating common cardiac arrhythmias, more and more cases of severe neutropenia and occasional deaths have been reported." | 3.67 | Severe neutropenia due to sustained-release procainamide. ( Hoyt, RE, 1987) |
"Procainamide therapy has frequently been reported as a cause of agranulocytosis, but severe thrombocytopenia associated with the use of this drug has been noted only once." | 3.66 | Procainamide-induced agranulocytosis and thrombocytopenia. ( Amorosi, EL; Rothman, IK, 1979) |
"Bone marrow granulomas and neutropenia occurred in a 77-year-old man following the ingestion of procainamide hydrochloride for 50 days." | 3.66 | Bone marrow granulomas and neutropenia associated with procainamide. Report of a case. ( Baker, J; Riker, J; Swanson, M, 1978) |
"The case of a 69-year-old woman with procainamide-induced agranulocytosis is reported, and literature reports of 14 other such cases are reviewed." | 3.65 | Agranulocytosis associated with procainamide therapy--report of a case. ( Brown, BT; Jacknowitz, AI; Prince, RA, 1977) |
"A 73-year-old woman was found to have clinically significant pancytopenia in association with procainamide hydrochloride ingestion." | 3.65 | Severe transient pancytopenia associated with procainamide ingestion. ( Bluming, AZ; Plotkin, D; Rosen, P; Thiessen, AR, 1976) |
"We have presented two cases of agranulocytosis occurring in patients receiving a combination antiarrhythmic regimen." | 1.26 | Agranulocytosis during combined procainamide and phenytoin therapy. ( Crook, JE; Leftwich, RB; Natelson, EA; Woosley, RL, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 39 (92.86) | 18.7374 |
1990's | 3 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
FABREGOULE, M | 1 |
MESSERSCHMITT, J | 1 |
TALMERS, FN | 1 |
TELMOS, AJ | 1 |
INOUYE, M | 1 |
MILLAR, J | 1 |
TOWNSEND, JH | 1 |
Azócar, J | 1 |
Nagesh, KG | 1 |
Poulose, KP | 1 |
Tseng, TH | 1 |
Schadchehr, A | 1 |
Woosley, RL | 2 |
Roden, DM | 1 |
Nelson, JC | 1 |
Lutton, JD | 1 |
Fass, AE | 1 |
Anderson, S | 1 |
Wenger, NK | 1 |
Reidy, TJ | 1 |
Upshaw, JD | 1 |
Clary, RM | 1 |
Beazley, WS | 1 |
Henley, RW | 1 |
Ellrodt, AG | 2 |
Murata, GH | 1 |
Riedinger, MS | 1 |
Stewart, ME | 1 |
Mochizuki, C | 1 |
Gray, R | 1 |
Fleet, S | 1 |
Christensen, DJ | 1 |
Palma, LF | 1 |
Phelps, K | 1 |
Berger, BE | 1 |
Hauser, DJ | 1 |
Rollag, A | 1 |
Knipping, W | 1 |
Abe, H | 1 |
Suzuka, H | 1 |
Tasaki, H | 1 |
Kuroiwa, A | 1 |
Starkebaum, G | 1 |
Kenyon, CM | 1 |
Simrell, CR | 1 |
Creamer, JI | 1 |
Rubin, RL | 1 |
Rothman, IK | 1 |
Amorosi, EL | 1 |
Crook, JE | 1 |
Leftwich, RB | 1 |
Natelson, EA | 1 |
Prince, RA | 1 |
Brown, BT | 1 |
Jacknowitz, AI | 1 |
van Beek, RJ | 1 |
Bieger, R | 1 |
den Ottolander, GJ | 1 |
Riker, J | 1 |
Baker, J | 1 |
Swanson, M | 1 |
Bluming, AZ | 1 |
Plotkin, D | 1 |
Rosen, P | 1 |
Thiessen, AR | 1 |
Chelius, CJ | 1 |
Nunag, AN | 1 |
Hoffman, HS | 1 |
Freed, JS | 1 |
Reiner, MA | 1 |
Malters, PB | 1 |
Salem, AG | 1 |
Hoyt, RE | 1 |
Kimmel, DP | 1 |
Antignano, LV | 1 |
Barold, SS | 1 |
Boros, L | 2 |
Olson, JP | 1 |
Meyers, DG | 1 |
Gonzalez, ER | 1 |
Peters, LL | 1 |
Davis, RB | 1 |
Feagler, JR | 1 |
Egan, JD | 1 |
Nair, CK | 1 |
Katkov, W | 1 |
Konttinen, YP | 2 |
Tuominen, L | 2 |
Golochevskaia, VS | 1 |
Hensen, A | 1 |
Gunay, U | 1 |
Honig, GR | 1 |
Hickson, B | 1 |
Davidson, RJ | 1 |
Walker, W | 1 |
Ream, CR | 1 |
Barrera, R | 1 |
Wang, RI | 1 |
Schuller, G | 1 |
2 reviews available for procainamide and Agranulocytosis
Article | Year |
---|---|
Septic complications of procainamide-induced agranulocytosis: report of two cases.
Topics: Aged; Agranulocytosis; Escherichia coli Infections; Female; Humans; Male; Procainamide; Pseudomonas | 1988 |
[Side effects of anti-arrhythmic agents].
Topics: 1-Propanol; Adrenal Cortex Hormones; Agranulocytosis; Anorexia Nervosa; Anti-Arrhythmia Agents; Anti | 1971 |
40 other studies available for procainamide and Agranulocytosis
Article | Year |
---|---|
[Agranulocytosis during procaine amide treatment].
Topics: Agranulocytosis; Humans; Procainamide | 1954 |
A CASE REPORT: PROCAINE AMIDE HYDROCHLORIDE (PRONESTYL) INDUCED AGRANULOCYTOSIS.
Topics: Agranulocytosis; Drug Therapy; Geriatrics; Humans; Procainamide; Toxicology; Ventricular Fibrillatio | 1965 |
Agranulocytosis following maintenance dosage of pronestyl; report of severe case with recovery.
Topics: Agranulocytosis; Biological Phenomena; Physiological Phenomena; Procainamide; Procaine | 1951 |
Anti-myeloid-cell antibody in procainamide-induced agranulocytosis.
Topics: Aged; Agranulocytosis; Autoantibodies; Bone Marrow; Humans; Male; Middle Aged; Procainamide | 1984 |
Procainamide-induced agranulocytosis: report of two cases and review.
Topics: Aged; Agranulocytosis; Cardiac Complexes, Premature; Child; Female; Heart Ventricles; Humans; Male; | 1980 |
Importance of metabolites in antiarrhythmic therapy.
Topics: Acecainide; Agranulocytosis; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Huma | 1983 |
Procainamide-induced agranulocytosis with reversible myeloid sensitivity.
Topics: Agranulocytosis; Bone Marrow; Colony-Forming Units Assay; Colony-Stimulating Factors; Granulocytes; | 1984 |
Sustained-release procainamide and neutropenia.
Topics: Agranulocytosis; Delayed-Action Preparations; Humans; Neutropenia; Procainamide | 1984 |
Procainamide-induced agranulocytosis.
Topics: Administration, Oral; Aged; Agranulocytosis; Delayed-Action Preparations; Female; Humans; Male; Midd | 1984 |
Fatal typhlitis secondary to procainamide-induced agranulocytosis.
Topics: Aged; Agranulocytosis; Cecal Diseases; Female; Humans; Inflammation; Procainamide | 1984 |
Severe neutropenia associated with sustained-release procainamide.
Topics: Aged; Agranulocytosis; Benzothiadiazines; Cardiac Surgical Procedures; Delayed-Action Preparations; | 1984 |
Agranulocytosis, procainamide, and phenytoin.
Topics: Aged; Agranulocytosis; Humans; Male; Phenytoin; Procainamide | 1984 |
Procainamide and neutropenia.
Topics: Aged; Agranulocytosis; Delayed-Action Preparations; Humans; Male; Neutropenia; Procainamide | 1984 |
Agranulocytosis, thrombocytopenia, and procainamide.
Topics: Aged; Agranulocytosis; Delayed-Action Preparations; Female; Humans; Male; Procainamide; Thrombocytop | 1984 |
Agranulocytosis due to new sustained-release procainamide.
Topics: Administration, Oral; Aged; Agranulocytosis; Arrhythmias, Cardiac; Delayed-Action Preparations; Huma | 1983 |
[Procainamide induced agranulocytosis].
Topics: Aged; Agranulocytosis; Humans; Male; Procainamide | 1982 |
[Problems of evaluating rare adverse drug reactions using as an example agranulocytosis induced by anti-arrhythmia agents].
Topics: Aged; Agranulocytosis; Ajmaline; Anti-Arrhythmia Agents; Drug Therapy, Combination; Drug-Related Sid | 1980 |
Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction.
Topics: Aged; Agranulocytosis; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Cell Count; Delayed-Action | 1995 |
Procainamide-induced agranulocytosis differs serologically and clinically from procainamide-induced lupus.
Topics: Aged; Aged, 80 and over; Agranulocytosis; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antinu | 1996 |
Procainamide-induced agranulocytosis and thrombocytopenia.
Topics: Aged; Agranulocytosis; Arteriosclerosis; Humans; Male; Procainamide; Thrombocytopenia | 1979 |
Agranulocytosis during combined procainamide and phenytoin therapy.
Topics: Acetylation; Acetyltransferases; Aged; Agranulocytosis; Arrhythmias, Cardiac; Drug Therapy, Combinat | 1979 |
Agranulocytosis associated with procainamide therapy--report of a case.
Topics: Aged; Agranulocytosis; Arrhythmias, Cardiac; Female; Humans; Leukocyte Count; Procainamide; Time Fac | 1977 |
Reversible severe anaemia and granulocytopenia caused by procainamide. A case report.
Topics: Agranulocytosis; Anemia; Humans; Male; Middle Aged; Procainamide | 1978 |
Bone marrow granulomas and neutropenia associated with procainamide. Report of a case.
Topics: Aged; Agranulocytosis; Bone Marrow Diseases; Granuloma; Humans; Male; Neutropenia; Procainamide | 1978 |
Severe transient pancytopenia associated with procainamide ingestion.
Topics: Aged; Agranulocytosis; Female; Humans; Myocardial Infarction; Pancytopenia; Procainamide | 1976 |
Procainamide reactions.
Topics: Aged; Agranulocytosis; Drug Hypersensitivity; Humans; Male; Middle Aged; Procainamide; Respiratory T | 1975 |
Severe neutropenia with procainamide therapy.
Topics: Aged; Agranulocytosis; Humans; Male; Neutropenia; Procainamide | 1990 |
Agranulocytosis secondary to extended-release procainamide: a case report and review of the literature. A case of agranulocytosis caused by procainamide in a patient who had undergone open-heart surgery.
Topics: Agranulocytosis; Angina Pectoris; Angina, Unstable; Delayed-Action Preparations; Humans; Male; Middl | 1987 |
Severe neutropenia due to sustained-release procainamide.
Topics: Aged; Agranulocytosis; Delayed-Action Preparations; Humans; Male; Neutropenia; Procainamide; Tachyca | 1987 |
Neutropenia associated with procainamide.
Topics: Aged; Agranulocytosis; Female; Heart Diseases; Humans; Male; Neutropenia; Procainamide | 1985 |
Correction: procainamide versus Procan SR.
Topics: Agranulocytosis; Humans; Neutropenia; Procainamide | 1985 |
Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.
Topics: Aged; Agranulocytosis; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Neutropenia; | 1985 |
Neutropenia and procainamide.
Topics: Agranulocytosis; Humans; Neutropenia; Procainamide | 1985 |
Reversible procainamide-induced agranulocytosis twice in one patient.
Topics: Adenocarcinoma; Aged; Agranulocytosis; Coronary Disease; Female; Heart Neoplasms; Humans; Myocardial | 1971 |
[Agranulocytosis caused by procainamide (Pronestyl)].
Topics: Aged; Agranulocytosis; Angina Pectoris; Cardiac Complexes, Premature; Female; Humans; Procainamide | 1974 |
Agranulocytosis in a 12-year-old girl treated with procainamide.
Topics: Agranulocytosis; Arrhythmias, Cardiac; Blood Cell Count; Child; Female; Humans; Procainamide | 1974 |
Agranulocytosis caused by procainamide.
Topics: Acute Kidney Injury; Aged; Agranulocytosis; Anemia; Antibodies, Antinuclear; Anuria; Erythropoiesis; | 1972 |
[Procaine amide-induced agranulocytosis].
Topics: Aged; Agranulocytosis; Creatinine; Female; Humans; Kidney; Procainamide; Ventricular Fibrillation | 1972 |
Desensitization to procainamide.
Topics: Agranulocytosis; Arrhythmias, Cardiac; Desensitization, Immunologic; Humans; Leukopenia; Male; Methy | 1970 |
Agranulocytosis following procainamide administration.
Topics: Aged; Agranulocytosis; Blood Cell Count; Bone Marrow Examination; Humans; Male; Procainamide; Tachyc | 1969 |